Results 81 to 90 of about 84,091 (291)
Patient information, education and self-management in bronchiectasis: facilitating improvements to optimise health outcomes [PDF]
, 2018 Background: Bronchiectasis is an incurable lung disease characterised by irreversible airway dilatation. It causes symptoms including chronic productive cough, dyspnoea, and recurrent respiratory infections often requiring hospital admission.
De Soyza, Anthony +3 more
core +3 more sources
Scientific Reports, 2021 This study investigated the impact of bronchiectasis on patients admitted to the intensive care unit (ICU) at a hospital in Korea. Patients with bronchiectasis were diagnosed using results of chest computed tomography performed before ICU admission.
Youngmok Park +11 more
doaj +1 more source
Acta Paediatrica, EarlyView.ABSTRACT Aim Post‐infectious bronchiolitis obliterans (PIBO) is a rare but severe chronic paediatric obstructive lung disease, characterised by the obliteration of small airways following severe lower respiratory tract infections. Epidemiological data in Europe remain limited. Methods This multicentre retrospective study examined the characteristics of
Julie Mazenq +24 more
wiley +1 more source
Bronchiectasis:a case-based approach to investigation and management [PDF]
, 2018 Bronchiectasis is a chronic respiratory disease characterised by a syndrome of productive cough and recurrent respiratory infections due to permanent dilatation of the bronchi.
Agarwal +17 more
core +3 more sources
Respiratory Research, 2018 Background Cardiovascular disease are common co-morbidities in bronchiectasis and contribute substantially to disease burden and mortality. Brachial-ankle pulse wave velocity (baPWV), a measure of arterial stiffness, has a strong predictive value for ...
Yong-hua Gao +6 more
doaj +1 more source
Prevalence and early outcome of bronchiectasis as an atypical presentation in COVID-19 patients
The Egyptian Journal of Bronchology, 2022 Introduction Bronchiectasis was considered as an uncommon radiological feature of corona virus disease 2019 (COVID-19) infection. The clinical course and outcome of COVID-19 bronchiectasis overlap is still a point for research.
Aliae A. R. Mohamed Hussein +3 more
doaj +1 more source
Clinical &Experimental Allergy, EarlyView.Almost one in five patients receiving biological treatment for severe asthma has comorbid atopic dermatitis. Patients with comorbid atopic dermatitis represent a distinct phenotype with early‐onset, allergic asthma. Comorbid atopic dermatitis impacts the choice of biologic for severe asthma in real‐life practice. IgE, immunoglobulin E; FeNO, fractional
Marianne Baastrup Soendergaard +14 more
wiley +1 more source
Bronchiectasis in India:results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry [PDF]
, 2019 BACKGROUND: Bronchiectasis is a common but neglected chronic lung disease. Most epidemiological data are limited to cohorts from Europe and the USA, with few data from low-income and middle-income countries.
Aleemuddin, Naveed M. +63 more
core +5 more sources
High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk
BMC Pulmonary MedicineBackground Elevation of systemic inflammatory markers were found to correlate with increased disease extent, reduced lung function and higher risk of future severe exacerbations in patients with bronchiectasis.
Wang Chun Kwok +3 more
doaj +1 more source
Respiratory admissions and impact of COVID‐19 lockdowns for children with severe cerebral palsy
Developmental Medicine &Child Neurology, EarlyView.In a population cohort of children with severe cerebral palsy, there was a reduced frequency of hospitalization for respiratory illness during periods of restricted social contact, implemented to reduce transmission of COVID‐19. This mirrored trends in the wider population and underlines the importance of community viral transmission in these children.
Susan M. Reid +9 more
wiley +1 more source